CITY OF MEXICO.
There are many myths about the state.
One in three people living with HIV in Latin America does not know this, mainly because of the stigma associated with this disease, because there is no culture of prevention, said Carlos Magis of the National Center for Prevention and Control of HIV / AIDS (Censida)
"There is still a delay in diagnosis despite the fact that a person who has been diagnosed and treated in a timely manner has a high life expectancy," said Magis, director of comprehensive care for Censida.
The doctor explained that with existing treatments the life expectancy is 40 years for people infected with this virus.
Brenda Crabtree Ramirez, the local president of the International Society for AIDS, stressed that violence, stigma and inequality for access to prevention and information have become the most important obstacles to overcoming.
"The fact is that as long as we are not fighting this, the AIDS epidemic can not be effectively attacked," he said.
Experts have said that among people who have the least detection, they are mostly heterosexual men and older.
"Especially in this second group, they are slowly realizing that they are in danger because there is a great deal of stigma associated with this disease," said Huan Sierra, head of the Department of Infection at the Mexican Institute of Medical Sciences and Food Salvador Zubiran.
In Mexico, according to Censida, more than 141,000 people are receiving retroviral treatment, and since 1996 mortality has been reduced, although there are still 5,000 deaths a year from this disease.
"With the treatments we offer in the Ministry of Health, patients are better and 51% of those who are diagnosed and treated reduced the viral load in six months," Magis said.
He added that one of the disadvantages in the region is that pharmacy tests are not yet available to the population, which is available in countries like the United States to anyone who wants to test quickly.
He added that reducing the cost of treatment would be of great help in countries such as Mexico, where the cost of HIV treatment takes a third of the disaster fund for Seguro Populara.
"Public policy should aim at improving access to treatment, and one option is to cut costs, make consolidated drug purchases and allow more drugs to Mexico," he said.
He explained that in regions such as Africa, the cost of treatment is $ 100 a year, thanks to the fact that the therapy is based on generic retrovirals; while in Mexico the cost is increased to $ 2,000 because it is based on patents.
Sierra said that a HIV patient in Mexico, in addition to stigma and discrimination, has to face the hostile health system that will monitor the treatment.
"Unfortunately, we have a fragmented health system and this is not very useful for people who have diseases that need to be treated for life, sometimes institutions are an obstacle to the continuity needed to treat HIV," he said.
A photo project that will make you see HIV with different eyes